Be the first to like this
Poor internal brand and disease state communications can be a factor wherein a promising pharmaceutical product fails to meet expectations. Successful brand leaders must understand how and when to deliver key messages to all audiences -- including internal stakeholders -- to realize best new product results.
This study is designed to help product teams/internal communication groups avoid common pitfalls in internal communications that can hinder brand performance. The research also identifies and details 10 best practices for internal brand and disease state communications. Also covered are tactics, strategies and channels that are most effective for pre-launch disease state communication to employees across all job levels, corporate functions and therapeutic areas.